Grit Biotechnology Announces Closing of $60 Million Series B Financing

/PRNewswire/ -- On September 8, 2023, Grit Biotechnology announced the completion of a Series B financing round, raising over 60 million USD. The investment...

Related Keywords

Decheng ,Guangdong ,China ,Beijing ,Qingdao ,Shandong ,Zhengzhou ,Henan ,Yuanhe ,Shanghai ,Suzhou ,Jiangsu ,Shenzhen ,Jin Haitao ,Qianhai Ark ,Liando Group ,Hefangtian Venture Partnership ,Qianhai Ark Asset Management Co Ltd ,China International Capital Corporation Limited ,Asset Management Association Of China ,Shenzhen Capital Group ,Grit Biotechnology ,Yuanhe Capital ,Sherpa Healthcare Partners ,Decheng Capital ,Matrix Partners ,Tumor Infiltrating Lymphocyte ,Grit Bio ,Vice Chairman ,Asset Management Association ,Liandou Valley ,